Figure 3. Hemoglobin levels and platelet counts over time. Ruxolitinib includes both the randomized and extension phases; BAT includes the randomized phase only and not the assessments after crossover.
Figure 3

Hemoglobin levels and platelet counts over time. Ruxolitinib includes both the randomized and extension phases; BAT includes the randomized phase only and not the assessments after crossover.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal